Beckman Coulter Diagnostics has appointed Catherine Jennings as its new President. In this role, Jennings will lead the company’s strategic, operational and organisational priorities, applying a culture of continuous improvement to accelerate innovation, strengthen global impact and help laboratories and clinicians deliver better patient outcomes. She brings more than 20 years of healthcare industry leadership […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.